Sir Niall Ferguson Joins The Times
The Times announces Sir Niall Ferguson has joined as a contributing writer and will write 12 exclusive pieces per year. He offers his unique insights…
Thought Leader: Niall Ferguson
By Scott Gottlieb (original source Health Affairs)
“In recent years, considerable bipartisan Congressional action, leadership from both Democratic and Republican administrations, and broad-based multistakeholder collaborations have focused on improving the tools and regulatory processes at the Food and Drug Administration (FDA), other government agencies, and public-private collaborations to support more efficient and timely development of new medical technologies. Enhanced funding through user fees and the bipartisan Twenty-First Century Cures legislation have supported a robust and better-resourced FDA and enabled science-driven collaborations in a range of areas including innovative clinical trials, “patient-focused” drug development, and greater clarity around standards for regulatory approval of new technologies.”
Click here to read more
Sir Niall Ferguson Joins The Times
The Times announces Sir Niall Ferguson has joined as a contributing writer and will write 12 exclusive pieces per year. He offers his unique insights…
Thought Leader: Niall Ferguson
Dr. Sanjay Gupta: Is Ozempic Really A Miracle Drug?
New drugs like Wegovy, Ozempic and Mounjaro are billed as a revolutionary new approach for losing weight. But are these actually miracle drugs? Dr. Sanjay…
Thought Leader: Sanjay Gupta
Peter Zeihan: The Geopolitics of Climate Change
From Peter Zeihan: With a glacier as the backdrop for this video, I figured it only appropriate to discuss resource exploitation, Arctic shipping, and agriculture…
Thought Leader: Peter Zeihan